Clinical Trial Update: A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ponatinib vs nilotinib in chronic phase chronic myeloid leukemia has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Phase Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)
• Ponatinib (ponatinib)

Snippet

Sponsor: Ariad Pharmaceuticals | Conditions: Chronic Phase Chronic Myeloid Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2021-11-26